Contract Manufacturing

WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility

First announced in June 2021, this site will be WuXi STA's second facility in the United States, offering expanded capacity and greater flexibili...

 August 17, 2022 | News

WuXi ATU Announces Licensing Agreement with Janssen for TESSA™ Technology

WuXi ATU will license to Janssen its TESSA™ technology, a high-performance system that can produce 10 times more adeno-associated viral (AAV) vectors...

 August 12, 2022 | News

Merck Becomes One of the First CDMOs to Provide Full Viral Vector Offering with Launch of VirusExpress® 293 Adeno-Associated Virus Production Platform

  Reduces process development time by an estimated 40 percent Enables biopharmaceutical companies to increase the speed to clinical manufacturing ...

 August 10, 2022 | News

GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine

GreenLight's messenger RNA production process is transferable to large-scale equipment and CMO facilities Technology transfer and scale-up from lab benc...

 August 02, 2022 | News

Samsung Biologics Reports Second Quarter 2022 Financial Results

Released consolidated financial position of the company based on its full acquisition of Samsung Bioepis completed on April 20, 2022 Achieved recor...

 July 28, 2022 | News

WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapore

This investment will establish a cutting-edge, fully integrated CRDMO center in Singapore, including a research and development service center and large-...

 July 20, 2022 | News

Samsung Biologics to purchase land for its second Bio Campus

Acquires additional land, sized 357,366㎡ valued at KRW 426 billion, for Bio Campus 2 Plans to build Multi-Modal Plant, Open Innovation,...

 July 19, 2022 | News

GenScript ProBio and DAAN Bio Therapeutics, Sign a Strategic Cooperation MOU for the Discovery and Development of Novel Drugs

Through this agreement, both companies will strategically cooperate in the overall development process, such as discovery, manufacturing, and clinical tria...

 July 15, 2022 | News

GenScript ProBio Signs MOU to Form Strategic Partnership with ACT Therapeutics to Development of New CAR-T Cell Therapies

GenScript ProBio and ACT Therapeutics are in the process of signing a contract for plasmid and virus vector development and production for the first pipe...

 July 13, 2022 | News

'Sustainable CDMO' Samsung Biologics releases 2022 ESG Report

Aims to build an eco-friendly business environment and achieve net zero GHG emissions in its operations, moving towards 100% renewable energy. Details n...

 July 12, 2022 | News

WuXi XDC and AbTis Sign Memorandum of Understanding for Development and Manufacturing of Antibody Drug Conjugates

Under the partnership, AbTis will have access to WuXi XDC's integrated services for linker and payload manufacturing, ADC conjugation process developm...

 July 08, 2022 | News

WuXi STA Opens New Large-scale Oligonucleotide and Peptide Manufacturing Facility

WuXi STA, a subsidiary of WuXi AppTec, today announced the opening of a new large-scale oligonucleotide and peptide manufacturing facility at its Chan...

 July 07, 2022 | News

WuXi Biologics Extends Capabilities to Include Development and cGMP Manufacturing for Microbial-Derived Products

WuXi Biologics ("WuXi Bio") (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), announced that its MFG14 fac...

 July 05, 2022 | News

Catalent Expands Primary Packaging Capabilities at its Clinical Supply Facility in Shiga, Japan

The new blister packaging equipment is identical to that available across Catalent's clinical supply services network, offering maximum access and flexibil...

 June 30, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close